Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Impact on Cortisol Levels in Hypogonadal Women
NCT05302726Unknown
- Sponsor
- Rigshospitalet
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of DehydraTECH-estrogen in Hypogonadism, sponsored by Rigshospitalet. Primary endpoint: Serum Cortisol after Oral Estrogen at 3 months. Status: unknown.
02
Drugs
DehydraTECH-estrogen
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT05302726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05302726.